Geriatrics

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes

FDA Alerts

FDA Alert
fda alert
FDA Alert
FDA Approves First Nalmefene Hydrochloride Auto-Injector to Reverse Opioid Overdose
08/23/2024
Anthony Calabro, MA
The first nalmefene hydrochloride auto-injector is another emergency treatment tool to reverse known or suspected opioid overdose.
08/23/2024
FDA Alert
fda alert
FDA Alert
FDA Approves First Nalmefene Hydrochloride Auto-Injector to Reverse Opioid Overdose
08/23/2024
Anthony Calabro, MA
The first nalmefene hydrochloride auto-injector is another emergency treatment tool to reverse known or suspected opioid overdose.
08/23/2024
FDA Alert
fda alert
FDA Alert
FDA Approves First Nalmefene Hydrochloride Auto-Injector to Reverse Opioid Overdose
08/23/2024
Anthony Calabro, MA
The first nalmefene hydrochloride auto-injector is another emergency treatment tool to reverse known or suspected opioid overdose.
08/23/2024
FDA Alert
fda alert
FDA Alert
FDA Approves First Nalmefene Hydrochloride Auto-Injector to Reverse Opioid Overdose
08/23/2024
Anthony Calabro, MA
The first nalmefene hydrochloride auto-injector is another emergency treatment tool to reverse known or suspected opioid overdose.
08/23/2024
FDA Alert
shutterstock
FDA Alert
FDA Approves Epinephrine Nasal Spray for Allergic Reactions, Anaphylaxis
08/19/2024
Anthony Calabro, MA
The nasal spray is the first FDA-approved epinephrine product for the treatment of anaphylaxis not to be administered by injection.
08/19/2024
FDA Alert
shutterstock
FDA Alert
FDA Approves Epinephrine Nasal Spray for Allergic Reactions, Anaphylaxis
08/19/2024
Anthony Calabro, MA
The nasal spray is the first FDA-approved epinephrine product for the treatment of anaphylaxis not to be administered by injection.
08/19/2024
FDA Alert
shutterstock
FDA Alert
FDA Approves Epinephrine Nasal Spray for Allergic Reactions, Anaphylaxis
08/19/2024
Anthony Calabro, MA
The nasal spray is the first FDA-approved epinephrine product for the treatment of anaphylaxis not to be administered by injection.
08/19/2024
FDA Alert
shutterstock
FDA Alert
FDA Approves Epinephrine Nasal Spray for Allergic Reactions, Anaphylaxis
08/19/2024
Anthony Calabro, MA
The nasal spray is the first FDA-approved epinephrine product for the treatment of anaphylaxis not to be administered by injection.
08/19/2024
FDA Alert
shutterstock
FDA Alert
FDA Approves Epinephrine Nasal Spray for Allergic Reactions, Anaphylaxis
08/19/2024
Anthony Calabro, MA
The nasal spray is the first FDA-approved epinephrine product for the treatment of anaphylaxis not to be administered by injection.
08/19/2024
FDA Alert
shutterstock
FDA Alert
FDA Approves Epinephrine Nasal Spray for Allergic Reactions, Anaphylaxis
08/19/2024
Anthony Calabro, MA
The nasal spray is the first FDA-approved epinephrine product for the treatment of anaphylaxis not to be administered by injection.
08/19/2024